Genius Sports Limited (GENI) concluded trading on Wednesday at a closing price of $9.65, with 7.3 million shares of worth about $70.4 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 27.81% during that period and on Wednesday the price saw a gain of about 3.21%. Currently the company’s common shares owned by public are about 239.82M shares, out of which, 216.07M shares are available for trading.
Stock saw a price change of 2.66% in past 5 days and over the past one month there was a price change of -2.62%. Year-to-date (YTD), GENI shares are showing a performance of 11.56% which increased to 65.81% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $4.91 but also hit the highest price of $10.33 during that period. The average intraday trading volume for Genius Sports Limited shares is 2.67 million. The stock is currently trading 5.48% above its 20-day simple moving average (SMA20), while that difference is up 6.08% for SMA50 and it goes to 23.95% higher than SMA200.
Genius Sports Limited (NYSE: GENI) currently have 239.82M outstanding shares and institutions hold larger chunk of about 76.61% of that.
The stock has a current market capitalization of $2.49B and its 3Y-monthly beta is at 2.03. It has posted earnings per share of -$0.28 in the same period. It has Quick Ratio of 1.42 while making debt-to-equity ratio of 0.01. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GENI, volatility over the week remained 5.11% while standing at 5.90% over the month.
Stock’s fiscal year EPS is expected to rise by 116.91% while it is estimated to increase by 288.59% in next year.
Coverage by Guggenheim stated Genius Sports Limited (GENI) stock as a Buy in their note to investors on March 18, 2025, suggesting a price target of $12 for the stock. On June 13, 2024, Citigroup Resumed their recommendations, while on April 16, 2024, Goldman Initiated their ratings for the stock with a price target of $7.50. Stock get a Buy rating from B. Riley Securities on April 05, 2024.
